Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. 4 Exercise or conversion President and CEO acquired 11,855 shares (option exercise)
  2. 4 Open-market sale Chief Operating Officer sold 6,250 shares at $39.43 ($246,438)
  3. 4 Open-market sale President and CEO sold 261,692 shares at an average $33.24 ($8,697,528)
  4. 4 Open-market sale Chief Operating Officer sold 12,500 shares at $29.43 ($367,875)
  5. 4 Open-market sale CFO, CBO sold 10,000 shares at $29.00 ($290,000)
  6. 4 Open-market sale President and CEO sold 116,901 shares at an average $28.69 ($3,354,384)
  7. 4 Open-market sale President and CEO sold 88,055 shares at an average $26.86 ($2,365,540)
  8. 4 Open-market sale CFO, CBO sold 10,000 shares at $26.00 ($260,000)
  9. 4 Open-market sale President and CEO sold 29,621 shares at an average $22.30 ($660,558)
  10. 4 Open-market sale CFO, CBO sold 10,000 shares at $23.00 ($230,000)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale President and CEO sold 75,335 shares at an average $22.02 ($1,658,527)
  14. 4 Open-market sale CFO, CBO sold 10,000 shares at $20.00 ($200,000)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 14 · 277 filings